Prospect Financial Services LLC Acurx Pharmaceuticals, Inc. Transaction History
Prospect Financial Services LLC
- $161 Billion
- Q3 2024
A detailed history of Prospect Financial Services LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Prospect Financial Services LLC holds 295,075 shares of ACXP stock, worth $383,597. This represents 0.35% of its overall portfolio holdings.
Number of Shares
295,075
Previous 278,100
6.1%
Holding current value
$383,597
Previous $626 Million
10.4%
% of portfolio
0.35%
Previous 0.48%
Shares
4 transactions
Others Institutions Holding ACXP
# of Institutions
26Shares Held
1.25MCall Options Held
9.3KPut Options Held
9.7K-
Vanguard Group Inc Valley Forge, PA529KShares$688,1530.0% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$190,4500.0% of portfolio
-
Morgan Stanley New York, NY46.2KShares$60,0610.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC44.8KShares$58,2140.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$56,5050.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $15M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...